Clinical Trials · NCT00473265

Bone Properties in Hypoparathyroidism: Effects of PTH

CompletedPhase 2/Phase 3Teriparatide (Approved)
Phase
Phase 2/Phase 3
Recruitment status
Completed
Sponsor
John P. Bilezikian
Enrollment
68
Start date
May 2004
Locations
1 site, United States
Primary endpoint
Requirements for Calcium Supplementation
View Teriparatide compound reference